4-氟-n-甲氧基-n-甲基苯甲酰胺 | 116332-54-8

• 物质功能分类: 有机原料 - 氨基化合物 - 酰胺类化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氟-n-甲氧基-n-甲基苯甲酰胺
• 中文别名: 4-氟-N-甲氧基-N-甲基-苯甲酰胺；N-甲氧基-N-甲基-4-氟苯甲酰胺；4-氟-N-甲氧基-N-甲基苯甲酰胺
• 英文名称: 4-fluoro-N-methoxy-N-methylbenzamide
• 英文别名: N-methoxy-N-methyl-4-fluorobenzamide
• CAS: 116332-54-8
• 化学式: C₉H₁₀FNO₂
• mdl: MFCD02179265
• 分子量: 183.182
• InChiKey: DSUFRPVVBZLHPI-UHFFFAOYSA-N

物化性质

• 沸点：
  301.6±25.0 °C(Predicted)
• 密度：
  1.179±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2924299090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  室温且干燥环境下使用。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-Fluoro-n-methoxy-n-methylbenzamide
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-Fluoro-n-methoxy-n-methylbenzamide
CAS number: 116332-54-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H10FNO2
Molecular weight: 183.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-氟-n-甲氧基-n-甲基苯甲酰胺 在 dipotassium peroxodisulfate 、 copper diacetate 、 ammonium acetate 、 溶剂黄146 、 lithium diisopropyl amide 作用下， 反应 21.92h， 生成 4-(4-氟苯基)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶基)-1H-咪唑
  参考文献：
  名称：

  Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase

  摘要：

  Members of three classes of pyridinylimidazoles bind with varying affinities to CSBP (p38) kinase which is a member of a stress-induced signal transduction pathway. Based upon SAR and protein homology modeling, the pharmacophore and three potential modes of binding to the enzyme are presented. For a subset of pyridinylimidazoles, binding is shown to correlate with inhibition of CSBP kinase activity, whereas no significant inhibition of PKA, PKC alpha and ERK kinase activity is observed. Copyright (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0968-0896(96)00212-x
• 作为产物：
  描述：

  在 双氧水 、 N,N-二异丙基乙胺 作用下， 以 水 、 乙腈 为溶剂， 反应 0.5h， 以78%的产率得到4-氟-n-甲氧基-n-甲基苯甲酰胺
  参考文献：
  名称：

  由胺和酰基三氟硼酸钾（KAT）合成不含偶联剂的仲和叔酰胺

  摘要：

  尽管对于大多数酰胺合成而言非常有效，但是羧酸的活化需要使用有问题的偶联剂，并且通常不适用于挑战性情况，例如N-甲基氨基酸。作为仲酰胺和叔酰胺的替代品，我们报告了通过快速氧化三氟硼酸亚胺（TIM）可以方便地合成。通过酸促进酰基三氟硼酸钾（KAT）和胺的缩合反应，可以轻松制备TIM，并且可以用过氧化氢将TIM干净快速地氧化为酰胺。整体转换可以通过一锅法或通过TIM隔离来进行。中性，两性离子的TIM的独特性，使得可能的三级酰胺的制备通过不能从其他羰基衍生物获得的亚胺鎓物种，可以在未保护的官能团（包括酸，醇和硫醚）存在下进行。在初步研究中，这种方法适用于长肽的后期修饰和N-甲基化短肽的迭代合成，而无需偶联剂。

  DOI：

  10.1039/d0sc01330g
• 作为试剂：
  描述：

  二甲羟胺盐酸盐 、 三乙胺 、 对氟苯甲酰氯 、 水 在 ice 、 乙醚 、 Sodium sulfate-III 、 4-氟-n-甲氧基-n-甲基苯甲酰胺 作用下， 以 二氯甲烷 为溶剂， 反应 4.25h， 生成 4-氟-n-甲氧基-n-甲基苯甲酰胺
  参考文献：
  名称：

  Substituted isoxazole derivatives and their use in pharmaceutics

  摘要：

  本发明涉及式(I)的取代异噁唑衍生物，其中基团R1、R2和R3的含义如描述中所述。本发明化合物具有免疫调节作用和/或抑制细胞因子释放作用，因此适用于治疗与免疫系统紊乱有关的疾病，特别是免疫介导的炎症性疾病。

  公开号：

  US20060128759A1

文献信息

• Dealkoxylation of <i>N</i>-alkoxyamides without an external reductant driven by Pd/Al cooperative catalysis
  作者：Hirotsugu Suzuki、Takahiro Shiomi、Kenji Yoneoka、Takanori Matsuda

  DOI：10.1039/d0ob01815e

  日期：——

  Lewis acid-assisted palladium-catalysed dealkoxylation of N-alkoxyamides has been realised in the absence of an external reductant.

  Lewis酸辅助钯催化的N-烷氧基酰胺脱烷氧化反应在无外部还原剂的情况下实现。
• A CO₂-Catalyzed Transamidation Reaction
  作者：Yang Yang、Jian Liu、Fadhil S. Kamounah、Gianluca Ciancaleoni、Ji-Woong Lee

  DOI：10.1021/acs.joc.1c02077

  日期：2021.12.3

  Transamidation reactions are often mediated by reactive substrates in the presence of overstoichiometric activating reagents and/or transition metal catalysts. Here we report the use of CO2 as a traceless catalyst: in the presence of catalytic amounts of CO2, transamidation reactions were accelerated with primary, secondary, and tertiary amide donors. Various amine nucleophiles including amino acid

  在过量化学计量的活化试剂和/或过渡金属催化剂的存在下，转酰胺基反应通常由反应性底物介导。在这里，我们报告了使用 CO 2作为无痕催化剂：在催化量的 CO 2存在下，使用伯、仲和叔酰胺供体加速转酰胺反应。包括氨基酸衍生物在内的各种胺类亲核试剂都被耐受，这表明转酰胺基在肽修饰和聚合物降解中的实用性（例如，Nylon-6,6）。特别是，N , O -二甲基羟基酰胺（Weinreb 酰胺）在 CO 2催化的转酰胺基反应中与 N 2相比表现出明显的反应性大气层。进行了比较 Hammett 研究和动力学分析，以阐明分子 CO 2的催化活化机制，这得到了 DFT 计算的支持。我们将CO 2在转酰胺基反应中的积极作用归因于通过与亲电子CO 2共价结合来稳定四面体中间体。
• An α‐Cyclopropanation of Carbonyl Derivatives by Oxidative Umpolung
  作者：Adriano Bauer、Giovanni Di Mauro、Jing Li、Nuno Maulide

  DOI：10.1002/anie.202007439

  日期：2020.10.5

  nucleophiles is often associated with umpolung and cationic mechanisms. Herein, we report a general process converting a range of ketone derivatives into α‐cyclopropanated ketones by oxidative umpolung. Mechanistic investigation and careful characterization of side products revealed that the reaction follows an unexpected pathway and suggests the intermediacy of non‐classical carbocations.

  碘 (III) 试剂对亲核试剂的反应性通常与 umpolung 和阳离子机制有关。在此，我们报告了通过氧化 umpolung 将一系列酮衍生物转化为 α-环丙烷化酮的一般过程。对副产物的机理研究和仔细表征表明，该反应遵循意想不到的途径，并表明非经典碳正离子的中间体。
• [EN] DIARYLMETHYLAMIDE DERIVATIVE HAVING MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISM<br/>[FR] DÉRIVÉ DE DIARYLMÉTHYLAMIDE PRÉSENTANT UNE ACTIVITÉ D'ANTAGONISTE DES RÉCEPTEURS DE L'HORMONE DE MÉLANO-CONCENTRATION
  申请人：MERCK SHARP & DOHME

  公开号：WO2011037771A1

  公开（公告）日：2011-03-31

  The present invention is directed to diarylmethylamide derivatives represented of structural formula I which are melanin-concentrating hormone receptor antagonists, and are useful as an agent for the prevention, treatment, or remedy of various circulatory diseases, neurological diseases, metabolic diseases, reproductive system diseases, respiratory diseases, digestive diseases, and the like. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the melanin-concentrating hormone is involved. I

  本发明涉及结构式I所代表的二芳基甲酰胺衍生物，其为黑色素浓集激素受体拮抗剂，并且可用作预防、治疗或缓解各种循环系统疾病、神经系统疾病、代谢性疾病、生殖系统疾病、呼吸系统疾病、消化系统疾病等的药物。该发明还涉及包含这些化合物的药物组合物以及在黑色素浓集激素参与的这些疾病的预防或治疗中使用这些化合物和组合物。
• [EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSES CHIMIQUES
  申请人：ASTRAZENECA AB

  公开号：WO2004011410A1

  公开（公告）日：2004-02-05

  Compounds of formula (I):wherein variable groups are as defined within; for use in the inhibition of 11βHSD1 are described.

  式(I)的化合物：其中变量基团如定义内；用于抑制11βHSD1。